Full-Time

Qualified Person

Posted on 9/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior, Expert

Oxford, UK

Expected to be in office 70% of the time with flexibility to work from home up to 30%.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Life Science degree and / or post-graduate.
  • 10 – 15 years of international quality experience in the biotechnology or pharmaceutical industry.
  • Must meet QP eligibility requirements combined with relevant biologics and steriles knowledge to be named on Manufacturer’s Authorisation from MHRA.
  • Meets requirements of continuing professional development required to maintain QP status.
  • Experience working in a GMP pharmaceutical / sterile / biological production environments.
  • Expert knowledge of Quality Management systems.
  • Extensive knowledge, interpretation and application of quality management within a GxP environment for early phase clinical trials & commercial products.
  • Demonstrates an in-depth understanding and proven application of the broader GMP principles, concepts, industry best practices, standards and trends.
  • Experienced Pharmaceutical Auditor.
  • Experience with hosting and participating in regulatory inspections.
  • Experience of influencing/leading others and implementing change.
Responsibilities
  • Being named as the Qualified Person on Moderna’s site licence(s).
  • Ensuring that all products are manufactured and released in compliance with EU directive 2002/83/EC.
  • Overseeing the release of biologically active intermediates and sterile products in line with cGMP, approved product descriptions, and regulatory filings.
  • Providing leadership in Quality Systems and Compliance QRM principles across the site, ensuring alignment with evolving regulatory expectations.
  • Maintaining oversight of the Quality Management System (QMS) as part of your operational responsibilities and escalating GMP concerns when necessary.
  • Representing Quality at Management Review Forum meetings and reporting on critical issues.
  • Leading self-inspections, external audits, and Quality Risk Assessments as required.
  • Delegating tasks to appropriately trained personnel or third parties and collaborating closely with the Quality Assurance team.
  • Acting as the QP point of contact for QA agreements, and reviewing and approving major/critical deviations, change proposals, and other quality records with potential batch impact.
  • Overseeing BMR and record reviews as part of the QP batch release process.
  • Keeping abreast of new and emerging regulatory guidance, ensuring company policies and procedures remain compliant.
  • Providing Quality oversight for commissioning, qualification, and validation initiatives, including complex GMP facilities and critical utility projects.
  • Collaborating cross-functionally to foster a strong Quality Culture and continuous improvement mindset.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

2%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna received a $176 million contract for a bird flu vaccine.
  • The company is expanding mRNA applications to personalized cancer vaccines.
  • Moderna is establishing a domestic mRNA production facility in Australia.

What critics are saying

  • Potential backlash in Australia for bypassing vaccine safety steps.
  • Possible removal from Nasdaq 100 Index could affect investor confidence.
  • Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for new categories of medicines.
  • The company integrates AI to optimize mRNA design and production processes.
  • Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

INACTIVE